Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Do they need to revaccinate/restart the vaccination schedule; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose August twenty twenty-three and August twenty twenty-four). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: Do they need to revaccinate/restart the vaccination schedule). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 25-AUG-2025 The pharmacist reported that the patient were administered with a first dose of Shingrix vaccine between August twenty twenty-three and August twenty twenty-four. Did they need to revaccinate/restart the vaccination schedule, was there any percentage drop on effectiveness. No specific vaccination date and patient demographics were obtained in this call. No vaccine detail was obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. This was 1 of the 5 cases, reported by the different reporter.; Sender's Comments: US-GSK-US2025109352:same reporter, different patient US-GSK-US2025109358:same reporter, different patient US-GSK-US2025109359:same reporter, different patient US-GSK-US2025109361:same reporter, different patient